Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1973 Jul;72(1):63–90.

Experimental Mycoplasma pulmonis Infection in Pathogen-Free Mice

Models for Studying Mycoplasmosis of the Respiratory Tract

J Russell Lindsey, Gail H Cassell
PMCID: PMC1903941  PMID: 4719529

Abstract

Mice of a Swiss substrain, reared under rigid pathogen-free (PF) conditions, were inoculated intranasally with broth cultures of Mycoplasma pulmonis ranging in dose from 101 to 9 × 109 colony forming units (CFU). A highly reproducible disease resulted with an LD50 of 1.3 × 108 CFU and a PD50 (dose producing pneumonia in 50% of mice) of 3.4 × 105 CFU. The inoculating dose of M pulmonis was found to be the critical determinant of the severity, duration and pathologic character of the respiratory disease produced. PF mice given 104 CFU or less developed a transient illness characterized by low frequencies of rhinitis, otitis media, laryngotracheitis and focal pneumonia. This was proposed as a low dose model. Doses of 105 to 109 CFU resulted in high frequencies of rhinitis, otitis media, laryngotracheitis and pneumonia. Within the first 10 days the pneumonia often was fatal, being characterized by an outpouring of neutrophils and edema fluid into alveolar spaces, pulmonary congestion and hemorrhage and, occasionally, pleuritis. This high dose—acute disease model was shown to be the result of seeding alveoli with large numbers of organisms at the time of intranasal inoculation. In animals surviving doses of 105 to 109 CFU beyond approximately 10 days postinoculation, the larger concentration of organisms was present in bronchi and bronchioles, giving rise to a third model, the high dose—chronic disease model. The predominant lesions were chronic suppurative bronchitis and bronchiolitis, marked peribronchial lymphoid cuffing, variable numbers of neutrophils and macrophages in alveoli, and complications such as bronchiectasis and pulmonary abscesses. Identical lesions were observed in axenic mice infected with M pulmonis. The infection in PF mice is considered a highly useful experimental system, both for comparative study of respiratory mycoplasmosis and for investigations directed toward understanding and eliminating the natural disease this agent causes in conventional mice and rats.

Full text

PDF
63

Images in this article

87Fig 8
on p.87
87Fig 9
on p.87
87Fig 10
on p.87
87Fig 11
on p.87
89Fig 12-13
on p.89
89Fig 14-15
on p.89
85Fig 1
on p.85
85Fig 2
on p.85
85Fig 3
on p.85
85Fig 4-5
on p.85
90Fig 16-20
on p.90
86Fig 6
on p.86
86Fig 7
on p.86

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brennan P. C., Fritz T. E., Flynn R. J. Role of Pasteurella pneumotropica and Mycoplasma pulmonis in murine pneumonia. J Bacteriol. 1969 Jan;97(1):337–349. doi: 10.1128/jb.97.1.337-349.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Butler M., Ellaway W. J. Growth and cytopathogenicity of mycoplasma in human and chicken trachea explants. J Comp Pathol. 1971 Jul;81(3):359–364. doi: 10.1016/0021-9975(71)90023-5. [DOI] [PubMed] [Google Scholar]
  3. Clyde W. A., Jr An experimental model for human mycoplasma disease. Yale J Biol Med. 1968 Apr-Jun;40(5-6):436–443. [PMC free article] [PubMed] [Google Scholar]
  4. Cole B. C., Miller M. L., Ward J. R. A comparative study on the virulence of Mycoplasma arthritidis and "Mycoplasma hominis, type 2" strains in rats. Proc Soc Exp Biol Med. 1967 Jan;124(1):103–107. doi: 10.3181/00379727-124-31676. [DOI] [PubMed] [Google Scholar]
  5. DAJANI A. S., CLYDE W. A., Jr, DENNY F. W. EXPERIMENTAL INFECTION WITH MYCOPLASMA PNEUMONIAE (EATON'S AGENT). J Exp Med. 1965 Jun 1;121:1071–1086. doi: 10.1084/jem.121.6.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Del Giudice R. A., Robillard N. F., Carski T. R. Immunofluorescence identification of Mycoplasma on agar by use of incident illumination. J Bacteriol. 1967 Apr;93(4):1205–1209. doi: 10.1128/jb.93.4.1205-1209.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Denny F. W., Clyde W. A., Jr, Glezen W. P. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis. 1971 Jan;123(1):74–92. doi: 10.1093/infdis/123.1.74. [DOI] [PubMed] [Google Scholar]
  8. Gay F. W., Maguire M. E., Baskerville A. Etiology of chronic pneumonia in rats and a study of the experimental disease in mice. Infect Immun. 1972 Jul;6(1):83–91. doi: 10.1128/iai.6.1.83-91.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hayflick L. Tissue cultures and mycoplasmas. Tex Rep Biol Med. 1965 Jun;23(Suppl):285+–285+. [PubMed] [Google Scholar]
  10. Lindsey J. R., Baker H. J., Overcash R. G., Cassell G. H., Hunt C. E. Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis. Am J Pathol. 1971 Sep;64(3):675–708. [PMC free article] [PubMed] [Google Scholar]
  11. Lipman R. P., Clyde W. A., Jr The interrelationship of virulence, cytadsorption, and peroxide formation in Mycoplasma pneumoniae. Proc Soc Exp Biol Med. 1969 Sep;131(4):1163–1167. doi: 10.3181/00379727-131-34061. [DOI] [PubMed] [Google Scholar]
  12. Lutsky I. I., Organick A. B. Pneumonia due to mycoplasma in gnotobiotic mice. I. Pathogenicity of Mycoplasma pneumoniae, Mycoplasma salivarium, and Mycoplasma pulmonis for the lungs of conventional and gnotobiotic mice. J Bacteriol. 1966 Oct;92(4):1154–1163. doi: 10.1128/jb.92.4.1154-1163.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Macpherson I., Russell W. Transformations in hamster cells mediated by mycoplasmas. Nature. 1966 Jun 25;210(5043):1343–1345. doi: 10.1038/2101343a0. [DOI] [PubMed] [Google Scholar]
  14. Madden D. L., Horton R. E., McCullough N. B. Mycoplasma gallisepticum infection in germfree and conventional chickens: experimental studies with a culture of low virulence. Am J Vet Res. 1967 Mar;28(123):517–526. [PubMed] [Google Scholar]
  15. Maniloff J., Morowitz H. J. Cell biology of the mycoplasmas. Bacteriol Rev. 1972 Sep;36(3):263–290. doi: 10.1128/br.36.3.263-290.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nelson J. B. Pathologic response of Swiss and Princeton mice to M. pulmonis. Ann N Y Acad Sci. 1967 Jul 28;143(1):778–783. doi: 10.1111/j.1749-6632.1967.tb27724.x. [DOI] [PubMed] [Google Scholar]
  17. PILGRIM H. I., DEOME K. B. Intraperitoneal pentobarbital anesthesia in mice. Exp Med Surg. 1955;13(4):401–403. [PubMed] [Google Scholar]
  18. Stanbridge E. Mycoplasmas and cell cultures. Bacteriol Rev. 1971 Jun;35(2):206–227. doi: 10.1128/br.35.2.206-227.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Thomas L. H., Smith G. S. Distribution of mycoplasmas in the non-pneumonic bovine respiratory tract. J Comp Pathol. 1972 Jan;82(1):1–4. doi: 10.1016/0021-9975(72)90019-9. [DOI] [PubMed] [Google Scholar]
  20. Thomas L. Mechanisms of pathogenesis in Mycoplasma infection. Harvey Lect. 1969;63:73–98. [PubMed] [Google Scholar]
  21. URMAN H. K., UNDERDAHL N. R., YOUNG G. A. Comparative histopathology of experimental swine influenza and virus pneumonia of pigs in disease-free, antibody-devoid pigs. Am J Vet Res. 1958 Oct;19(73):913–917. [PubMed] [Google Scholar]
  22. Weissmann G. Lysosomal mechanisms of tissue injury in arthritis. N Engl J Med. 1972 Jan 20;286(3):141–147. doi: 10.1056/NEJM197201202860307. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES